Search Results - "Eggertsen, Peter Preben"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study by Eggertsen, Peter Preben, Palmfeldt, Johan, Schytz, Henrik Winther, Hay, Debbie, Olsen, Rikke Katrine Jentoft, Nielsen, Jørgen Feldbæk

    Published in Journal of neurology (01-05-2024)
    “…Background Calcitonin gene-related peptide (CGRP) plays an important role in migraine pathophysiology, and post-traumatic headache (PTH) frequently presents…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Convergence insufficiency in patients with post-concussion syndrome is accompanied by a higher symptom load: a cross-sectional study by Nisted, Ivan, Hellemose, Line Amalie, Eggertsen, Peter Preben, Odgaard, Lene, Bek, Toke, Nielsen, Jørgen Feldbæk

    Published in Brain injury (02-07-2024)
    “…To estimate the prevalence of convergence insufficiency (CI) in adult patients with post-concussion syndrome and determine the impact of CI on symptom load…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Regression-based prognostic models for functional independence after postacute brain injury rehabilitation are not transportable: a systematic review by Pommerich, Uwe M., Stubbs, Peter W., Eggertsen, Peter Preben, Fabricius, Jesper, Nielsen, Jørgen Feldbæk

    Published in Journal of clinical epidemiology (01-04-2023)
    “…To identify and summarize validated multivariable prognostic models for the Functional Independence Measure® (FIM®) at discharge from post-acute inpatient…”
    Get full text
    Journal Article
  7. 7

    Inhibition of the Janus kinase-signal transducer and activator of transcription is a new treatment modality of rheumatoid arthritis by Frøling, Malte, Mikkelsen, Clara, Eggertsen, Peter Preben, Stern, Mette, van de Looij, Anne, Deleuran, Bent

    Published in Ugeskrift for læger (30-10-2017)
    “…Rheumatoid arthritis (RA) is a chronic inflammatory joint disease. The introduction of a new class of disease-modifying anti-rheumatic drugs, which work by…”
    Get more information
    Journal Article